MedTrace Logo

A Registry Study for Emergency Medical Service of Aneurysmal Subarachnoid Hemorrhage in China

NCT03115905 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2021-09-23

No results posted yet for this study

Summary

This is a staged registry study of early treatment strategy management of acute aneurysmal subarachnoid hemorrhage(aSAH) among different economic development levels areas in China.

First stage, the study will investigate and register the basic information of emergency treatment management for the acute aSAH in 20 different grade centers located in different economic levels districts including Northeast part, Northern, Eastern, South-central, Northwest, Southwest and Qinghai-Tibet of China. Comparing the the outcome of acute aSAH to find the critical factors to affect it by statistical analysis. Then,the investigators will offer some suggestions to adjust the measures to improve the efficacy of emergency medical service for acute SAH.

Second stage, to evaluate the outcome after applying the new suggestion of self-control methods.

The investigators hypothesis that there is an appropriate green pathway in different districts to shorten the rescuing time, improve the curative effects.

Conditions

  • Subarachnoid Hemorrhage, Aneurysmal
  • Emergency Medical Services

Sponsors & Collaborators

  • Ministry of Science and Technology of the People´s Republic of China

    collaborator OTHER_GOV

  • Xuanwu Hospital, Beijing

    lead OTHER

Principal Investigators

  • Hongqi Zhang, PhD. M.D · Xuanwu hosptial,Capital Medical University,China

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03115905 on ClinicalTrials.gov